EDF Health

The Trump EPA is throwing workers facing risks from new TSCA chemicals under the bus

Richard Denison, Ph.D., is a Lead Senior Scientist.

[For more on this topic, see our recent 3-part myth-busting series:
Part 1          Part 2         Part 3]

We have blogged before (see here and here) about the steps initiated in mid-2018 by the Trump EPA to weaken new chemical reviews under the Toxic Substances Control Act (TSCA) – rendering them even less health-protective than under TSCA prior to the 2016 reforms enacted in the Lautenberg Act.

As these debilitating policy changes – still never publicly described or released, and apparently still not written down even for use within EPA – have taken hold, we have seen dozens of flawed new chemical decisions emerge.  We blogged extensively about the first such decision made under the new regimen in late July 2018.  Since then, about 60 more final determinations reflecting the new policies have been posted on EPA’s website.  These decisions pertain mostly to premanufacture notifications (PMNs), along with a few for significant new use notices (SNUNs).  At least 80% of these chemicals were cleared to enter commerce without being subject to any conditions whatsoever.  EPA accomplished this by issuing a final determination that each cleared chemical, or significant new use of a chemical, is “not likely to present an unreasonable risk.”  For these determinations, EPA is required under TSCA to post a statement of its finding, which it does in another table on its website.

We have been closely examining these “not likely” determination documents.  Some deeply disturbing patterns are emerging.  This post will describe one of them.[pullquote]A new addition to the long and growing list of illegal actions EPA has taken to render the new chemicals program weaker than under the old TSCA.[/pullquote]

Most striking is that for a significant majority of these chemicals, EPA either identified significant risks to workers or indicated it had insufficient information to determine the level of risk to workers.  Under the 2016 reforms to TSCA, either finding – that there are or may be risks or that there is insufficient information to determine the level of risk – requires EPA to issue an order specifying conditions sufficient to eliminate the risk.  Yet EPA did no such thing; instead, it cleared the chemicals for unfettered market access.   Read More »

Posted in Health policy, Industry influence, Regulation, TSCA reform, Worker safety / Tagged , , | Read 2 Responses

The elephant in the room: potential biopersistence of short-chain PFAS

Maricel Maffini, Ph.D., Consultant and Tom Neltner, J.D., Chemicals Policy Director

In January 2018, US Food and Drug Administration (FDA) scientists published a peer-reviewed journal article stating a commonly used raw material to make greaseproof paper is likely to persist in the human body. FDA scientists’ sophisticated analysis and remarkable conclusion raises questions about the broad assumption that short-chain perfluorinated alkyl substances (PFAS), as a class, did not accumulate.

Strangely, two recent reviews funded by the FluoroCouncil, ignored FDA scientists’ study even though it was published ten months before the industry group submitted their analysis for peer-review. The peer reviewers appear to have missed the omission as well. As a result, the industry evaluations continue to perpetuate the flawed assumptions, concluding that perfluorohexanoic acid (PFHxA) and related short-chain PFAS “present negligible human health risk” and that this substance alone is a suitable marker for the “safety of fluorotelomer replacement chemistry.”

In this blog, we discuss the differences between the studies and the implications of the discordance between FDA’s and industry’s conclusions for the safety assessment of short-chain PFAS.

Read More »

Posted in Drinking water, FDA, Health policy, Health science, Public health, Regulation / Tagged , , , | Comments are closed

The Trump EPA’s actions on formaldehyde can be summed up in one word: Corrupt

Richard Denison, Ph.D., is a Lead Senior Scientist.

Today, Heidi Vogt at the Wall Street Journal reported on the systematic efforts by the Trump Administration to derail chemical assessments under the Environmental Protection Agency’s (EPA) Integrated Risk Information System (IRIS).   [pullquote]Decisions are being made as I write by conflicted EPA political appointees, not only to derail the beleaguered IRIS assessment for the carcinogen formaldehyde, but to transfer any further assessment of the chemical to be under the control of those same political appointees.[/pullquote]

The WSJ article cites an upcoming report by Congress’ Government Accountability Office (GAO) that notes “EPA leadership in October directed the heads of the agency’s various programs to limit the number of chemicals they wanted IRIS to study or continue researching.  Nine of 16 assessments were then dropped, including one that looked at whether exposure to formaldehyde increases the risk of leukemia that ‘has been drafted and is ready to be released for public comment.’ ”  The chemical industry has long sought to undermine the findings of numerous governmental authorities that have identified the dangers posed by formaldehyde, one of the industry’s biggest cash cows.

IRIS itself has also long been a target of the chemical and allied industries, including those well represented by EPA political appointees who are now able to drive the assault on IRIS from inside the agency.

This post will provide more of the backstory to the WSJ’s excellent reporting.  It reveals additional decisions being made as I write by conflicted political appointees, not only to derail the beleaguered IRIS assessment for formaldehyde, a known human carcinogen, but to transfer any further assessment of the chemical to be under the control of those same political appointees.  What is happening here we believe is ripe for further investigation.   Read More »

Posted in Health policy, Health science, Industry influence, TSCA reform / Tagged , , , , | Read 1 Response

Data visualization to drive clean air innovation and improve health

Aileen Nowlan, Senior Manager, EDF+Business

The first time I spoke at a conference about air pollution, the venue was right beside a daycare—a well-regarded chain, no doubt with significant waiting lists. But on the outside, the facility was steps from onramps to a bridge and a major highway, where horns blared and buses and trucks idled at the lights.

The pollution around this daycare was invisible, but because there is still so much we don’t know about air pollution, so were many of the risks.

Read More »

Posted in Air pollution, Health science, Hyperlocal mapping / Tagged , , , | Read 1 Response

EDF to OMB: Ban on methylene chloride in paint strippers must protect workers in addition to consumers

Lindsay McCormick, Project Manager, and Joanna Slaney, Legislative Director

[pullquote]

Over 11,000 concerned Americans have sent messages to Members of Congress over the last two weeks to urge EPA and OMB to protect workers – the population at most risk – from methylene chloride in paint strippers.

[/pullquote]Today, EDF met with the White House Office of Management and Budget (OMB) about the Environmental Protection Agency’s (EPA) draft final rule on methylene chloride-based paint strippers. We urged the office to ensure the ban on methylene chloride-based paint and coating removers covers both consumer and most commercial uses – as the agency originally proposed.

Removing these deadly products from stores, workplaces, and homes is a critical step to protecting public health. Methylene chloride is acutely lethal. Exposure to the chemical has led to over 50 reported worker deaths since the mid-1980s, more than 40 of which are attributed to use of methylene chloride-based paint strippers. Many more deaths have likely gone unreported. The chemical is also associated with a host of other serious health effects, including neurotoxicity, cancer, and liver impairment.

Despite the facts that workers represent the vast majority of reported deaths and face the highest risks of other health effects, it appears that EPA is poised to finalize a rule that excludes a ban on commercial uses entirely – and will instead merely initiate a lengthy, uncertain process that may lead to certification and training approaches EPA had already considered and rejected as inadequate to protect workers.

Read More »

Posted in Health policy, Public health, Regulation, TSCA reform / Tagged , , , , | Authors: / Comments are closed

New study: Using interactive online tools to publicize lead service line locations and promote replacement

By Sofia Hiltner, Rainer Romero, Lindsay McCormick and Tom Neltner

[pullquote]

EDF study evaluates interactive online tools in three Ohio cities that help users know which addresses have a lead service line.

[/pullquote]

In 2016, EPA called upon states to work with drinking water utilities to make publicly available the location of lead service lines (LSLs, the lead pipes that connect the main under the street to buildings) via maps or other mechanisms. Ohio led the way with legislation requiring more than 1,800 utilities to submit static PDF maps that showed where LSLs were likely to be present and then posting the maps online. Three cities in the state took the effort a step further to communicate the information to their customers by posting online tools. In 2016, Cincinnati posted an interactive map of LSLs modeled after one posted by Washington, DC earlier that year. The next year, Columbus posted an interactive map and Cleveland posted a search engine enabling anyone to check the service line material at an address.

Read More »

Posted in Drinking water, Lead, Public health / Tagged , , , , , , , | Comments are closed